February 26, 2024
GLP-1s are drugs proven to treat diabetes. But with high costs, increased use for other purposes and clinical uncertainty, GLP-1s are not without controversy. This brief underscores the history of these medications and makes policy recommendations to ensure patients are receiving the right drugs at the right time.
New from ACHP:
- ACHP Responds to RFI on the State of Artificial Intelligence in Health Care
- ACHP Urges HHS to Take Action to Prevent Future Cyberattacks
- Frequently Asked Questions on Broker Compensation Reform
- “Overcoming Barriers: Transforming Black Maternal Health Through Research” Webinar
- PODCAST: ACHP’s Ceci Connolly Joins Managed Healthcare Executive DC Roundtable Podcast
- OP-ED: What Could We Do if GLP-1 Weight Loss Drugs Were Free? Would Our Obesity Epidemic Be Solved for Good?